«Cancer is like a person's thumbprint; each person's cancer is uniquely theirs,» says Bill Hearl, CEO of Immunomic Therapeutics, a clinical
stage biotechnology company developing a nucleic acid immunotherapy platform with the potential to treat cancer, allergies and animal health issues.
• Myonexus Therapeutics, a New Albany, Oh. - based clinical -
stage biotechnology company developing transformative gene therapies for limb - girdle muscular dystrophies, raised $ 2.5 million in seed funding.
Not exact matches
A drug called PBT2,
developed by Australian
company Prana
Biotechnology, appears to improve cognitive abilities in patients with early -
stage Alzheimer's disease and reduce protein buildup blamed for the debilitating neurological disorder, researchers report in The Lancet Neurology.
A drug called PBT2,
developed by Australian
company Prana
Biotechnology, appears to improve cognitive abilities in patients with early -
stage Alzheimer's disease.
A2 Biotherapeutics is an early -
stage biotechnology company located in Southern California that
develops novel medicines for serious illnesses.
Gosselies, Belgium — January 4, 2017 — iTeos Therapeutics SA, a
biotechnology company developing novel cancer immunotherapies, today announced that it has regained exclusive worldwide rights from Pfizer to
develop and commercialise EOS200271, a highly selective, clinical -
stage IDO1 inhibitor.
Alachua, Fla. - based AGTC is a clinical -
stage biotechnology company that uses its proprietary gene therapy platform to
develop products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.